Coating processes – Medical or dental purpose product; parts; subcombinations;... – Particulate or unit-dosage-article base
Patent
1995-05-31
1997-02-04
Dudash, Diana
Coating processes
Medical or dental purpose product; parts; subcombinations;...
Particulate or unit-dosage-article base
424472, 514960, B05D 312, A61K 924, A61J 300
Patent
active
055995772
ABSTRACT:
A method of making solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a pharmaceutical suitable for the treatment of gastric disorders selected from the group consisting of cimetidine, ranitidine, famotidine, diphenoxylate, loperamide, loperamide-N-oxide, pharmaceutically acceptable salts thereof and combinations thereof; and a therapeutically effective amount of simethicone wherein the pharmaceutical and simethicone are separated by a barrier. The barrier is formed by coating with a polymer impermeable to simethicone.
REFERENCES:
patent: 3048526 (1962-08-01), Boswell
patent: 3767794 (1969-11-01), McVean et al.
patent: 4127650 (1975-03-01), Buchler
patent: 4198390 (1980-04-01), Rider
patent: 4316888 (1980-04-01), Nelson
patent: 4396604 (1983-08-01), Mitra
patent: 4857324 (1989-08-01), Mir et al.
patent: 5075114 (1991-12-01), Roche
patent: 5116847 (1992-05-01), Gilbert et al.
patent: 5248505 (1993-09-01), Garwin
patent: 5275819 (1994-01-01), Amer et al.
patent: 5288507 (1994-02-01), Sims
patent: 5417980 (1995-05-01), Goldman et al.
patent: 5447918 (1995-09-01), McCullough
J. Alfred Rider, "An Improved Simethicone Antacid Tablet", pp. 1033-1038 (1981) no month.
F. Maksoud, S. A. Said and M. Gourab, "Simethicone Use in Antacid Medications", pp. 35 and 36 (1976) no month.
J. K. Lalla and M. A. Sarkar, "Preparation and Stability Testing of Simethicone Emulsion", pp. 159-166 (1985) no month.
Cellulose Esters Polymer Characterization, Bulletin CE-2, FMC Corp. (1987) no month.
Cellulose Esters Polymers for Novel Drug Delivery, Bulletin CE-1, FMC Corp. (1986) no month.
CA115(24):263465f, Pharmaceutical Composition for Treating Gastrointestinal Distress (1991) no month.
CA111(2):12462a, Incorporation of Simethicone into Syrupy or Clear Base Liquid Orals (1989) no month.
CA97(13): 103890x, The Effect of Activated Dimethicone and an Proprietary Antacid Preparation Containing this Agent on the Absorption of Phenytoin (1982) no month.
CA96(25):210465p, The Effect of Activated Dimethicone, Other Antacid Constituents, and Kaolin on the Absorption of Propranolol (1982) no month.
CA93(14):138018p, Uniform Beadlike Particles Forming a Powder Surpuriya (1980) no month.
CA90(17):132533u, Interaction of Digoxin with Activated Dimethicone and Other Antacid Constituents (1979) no month.
CA107(4):28386g, Drugs in Combined Gastro-Soluble and Gastro-Resistant Form (1986) no month.
C71-S36634, Flatulence Treatment with Antifoaming-Compn (1974) no month.
C75-W80496, Medicaments for Treating Nervous Hyperacidity, Etc.-Contg. a Psychosedative, an Antacid, and an Antiflatuent (1975) no month.
Hoy Michael R.
Roche Edward J.
Stevens Charles A.
Dudash Diana
Mc-Neil-PPC, Inc.
Plantz Bernard F.
LandOfFree
Simethicone containing pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Simethicone containing pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Simethicone containing pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-676404